REPLIGEN CORP - 8-K Filing
Repligen reports Q3 2026 revenue of $209.3 million and raises full-year guidance following BioLife acquisition. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $RGEN
Read the full article at SEC EDGAR
Part of the story Cloudflare Shares Surge Following Strong Q3 Results and Raised Full-Year Guidance (85 articles)